Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 37,435 | 17,138 | 72,060 | 35,497 | 17,910 |
| Depreciation Amortization | 54,245 | 30,368 | 104,660 | 87,024 | 57,811 |
| Income taxes - deferred | 1,248 | 752 | -6,749 | 393 | 411 |
| Accounts receivable | -14,567 | 671 | -4,248 | -10,715 | -5,627 |
| Other Working Capital | -17,789 | -7,464 | -13,681 | -17,911 | -12,671 |
| Other Operating Activity | 17,840 | -2,218 | 3,150 | 8,296 | 5,212 |
| Operating Cash Flow | $78,412 | $39,247 | $155,192 | $102,584 | $63,046 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -201,105 | -103,150 | -366,662 | -228,997 | -93,018 |
| Other Investing Activity | -26,548 | 8,336 | -45,089 | 14,536 | 8,942 |
| Investing Cash Flow | $-227,653 | $-94,814 | $-411,751 | $-214,461 | $-84,076 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 675,289 | 477,600 | 704,340 | 556,544 | 155,131 |
| Debt Repayment | -564,953 | -441,884 | -522,486 | -448,436 | -156,036 |
| Common Stock Issued | 56,723 | 42,100 | 28,173 | 1,362 | 1,215 |
| Common Stock Repurchased | -27,946 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 24,815 | -3,485 | 41,195 | -3,129 | -463 |
| Financing Cash Flow | $163,928 | $74,331 | $251,222 | $106,341 | $-153 |
| Exchange Rate Effect | -20 | 98 | 220 | 380 | 35 |
| Beginning Cash Position | 47,209 | 47,209 | 52,326 | 52,326 | 52,326 |
| End Cash Position | 61,876 | 66,071 | 47,209 | 47,170 | 31,178 |
| Net Cash Flow | $14,667 | $18,862 | $-5,117 | $-5,156 | $-21,148 |
| Free Cash Flow | |||||
| Operating Cash Flow | 78,412 | 39,247 | 155,192 | 102,584 | 63,046 |
| Capital Expenditure | -226,229 | -112,821 | -432,336 | -277,860 | -128,678 |
| Free Cash Flow | -147,817 | -73,574 | -277,144 | -175,276 | -65,632 |